Influx Healthtech IPO Details
The Influx Healthtech IPO is a book build issue with a total issue size of ₹58.57 cr, comprising of fresh issue of 5000400 equity shares., and a offer for sale of 1100400 equity shares. Influx Healthtech IPO opened for subscription on Jun 18, 2025 and closed on Jun 20, 2025. Influx Healthtech IPO is set price band at ₹91 to ₹96 per share, with a lot size of 1200 shares. Minimum investment for Retail investors was ₹230,400.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Jun 23, 2025, and listed on the NSE on Jun 25, 2025.
Maashitla Securities Pvt. Limited has been appointed as the registrar. Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd are the Book Running Lead Manager for the issue.
Before investing in the Influx Healthtech IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 91 – 96
- Lot Size
- 1200
- Issue Size
- ₹58.57 Cr
- Minimum Investment
- ₹230400 (2400 Shares)
- Listing Date
- 25 June 2025
Current GMP
₹20 (+20.83%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Influx Healthtech Limited
Influx Healthtech, headquartered in Mumbai, is a prominent player in the healthcare sector, specializing in contract manufacturing and third-party production. The company operates three state-of-the-art manufacturing facilities in Thane, Maharashtra, spanning approximately 6,500 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively. Each facility is certified under GMP, HACCP, ISO 22000, and Halal standards, and is equipped with modern machinery, a dedicated quality control department, and a skilled workforce.
Influx Healthtech focuses on a diverse range of product categories, including dietary and nutritional supplements, cosmetics, ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company also manufactures active pharmaceutical ingredients (APIs) used in tablets, capsules, and injectable formulations.
Its Contract Development and Manufacturing Organization (CDMO) clientele includes well-known names such as Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. In Fiscal Year 2024, the production capacities for Unit 1, Unit 2, and Unit 3 were 1,100 kg, 1,700 kg, and 7,300 kg, respectively. Influx Healthtech employs a dedicated workforce of 165 permanent staff members.
Influx Healthtech IPO Promoters
- Mr. Munir Abdul Ganee Chandniwala
- Mrs. Shirin Munir Ahmed Chandniwala
- Mr. Abdul Ganee Abdul Rasul Chandniwala
Promoters Holding
Holding Pre Issue
99.85%
Holding Post Issue
73.53%
Influx Healthtech IPO Objective
The Company Influx Healthtech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes
Address / Contact Info
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com/
IPO Snapshot
Book Running Lead Managers
- Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Influx Healthtech IPO is a Book-building IPO with a total issue size of ₹58.57 crore. The Influx Healthtech IPO price band is ₹91 to 96 per share. The Influx Healthtech IPO subscription opens on Wed, Jun 18, 2025, and closes on Fri, Jun 20, 2025. The Influx Healthtech IPO will be listed on the NSE. Maashitla Securities Pvt. Limited is the registrar for the Influx Healthtech IPO.
The Influx Healthtech IPO opens on Wed, Jun 18, 2025 and closes on Fri, Jun 20, 2025
Influx Healthtech IPO Price Band is ₹91 to 96 per share.
Influx Healthtech IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹230400 based on the upper price band
The minimum investment for Influx Healthtech IPO is ₹230400, based on one lot of 1200 shares at the upper price band of ₹96 per share.
Investors can apply for the Influx Healthtech IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jun 20, 2025. The application amount remains blocked until the Influx Healthtech IPO allotment is finalized.
Influx Healthtech IPO issue size is ₹58.57 crores.
Influx Healthtech IPO allotment date is Wed, Jul 1, 2026.
The registrar for Influx Healthtech IPO is Maashitla Securities Pvt. Limited. Investors can go to Maashitla Securities Pvt. Limited website to check Influx Healthtech IPO allotment status, refund processing, and other IPO-related information.
The Influx Healthtech IPO GMP (Grey Market Premium) is ₹20 as of Wed, Jun 25, 2025. Based on the upper price band of ₹96 per share, the estimated Influx Healthtech IPO listing price is ₹116, indicating a potential listing gain of approximately 0% over the issue price.